Accord Healthcare recalls phenylephrine injection vials due to manufacturing deviations
Accord Healthcare is recalling Phenylephrine Hydrochloride Injection vials due to manufacturing deviations found during FDA inspection. No illnesses or injuries have been reported.
What this means for you
Minor labeling or packaging issue, or a voluntary precautionary recall. Risk of harm is low but real — follow the manufacturer's instructions.
Our severity reasoning: This is an FDA Class II recall with no reported illnesses or injuries. The hazard is based on manufacturing process deviations identified during inspection—a precautionary quality-control recall rather than confirmed product contamination or harm.
Plain-English summary
Accord Healthcare, Inc. is recalling Phenylephrine Hydrochloride Injection, USP 10 mg/mL, 1 mL single-dose vials manufactured by Intas Pharmaceuticals Limited in India. The product was distributed to the United States, Puerto Rico, and Canada. The recall affects 9,888 vials from batches R2101555, R2101538, and R2101564 with an expiration date of November 30, 2023.
The recall is due to Current Good Manufacturing Practice (CGMP) deviations identified during an FDA inspection of the manufacturing facility. The FDA has classified this as a Class II recall. No illnesses or injuries associated with this product have been reported.
The recalled product
- Product
- Phenylephrine Hydrochloride Injection, USP 10 mg/mL Rx Only, 1 mL Single Dose Vial, Manufactured for: Accord Healthcare, Inc., Durham, NC 27703 Manufactured by: Intas Pharmaceuticals Limited, Pharmez, Ahmedabad-382 213, INDIA; Vial NDC 16729-464-63, UPC 3 16729 46463 5; Carton ND
- Manufacturer
- Accord Healthcare, Inc.
- Hazard
- manufacturing-deviation
Is your product affected?
Check your packaging against the codes below. If any of them match, the product is part of this recall.
Lot numbers (4)
- Batches: R2101555
- R2101538
- R2101564
- Exp. Date 11/30/2023
Distribution
Distribution scope not specified by the agency.
Related recalls
Same category
- CriticalWarfarin Tablets Recalled After Mix-Up Between 2.5 mg and 5 mg Strengths
FDA (Drugs) · 2026-07-21
- ModerateFDA Recalls Pred Mild Ophthalmic Suspension Due to Failed Stability Specifications
FDA (Drugs) · 2026-06-03
- ModerateNicotine Transdermal System Patches Recalled for Oxidative Impurity Specification Failure
FDA (Drugs) · 2026-06-03
- LowPrimidone Tablets Recalled Due to Cross-Contamination with Acemetacin
FDA (Drugs) · 2026-05-27
- HighLiraglutide Injection Recalled Due to Particulate Matter in Cartridges
FDA (Drugs) · 2026-05-27